IHU: what the experts know about the B.1.640.2 variant found in France
While Omicron fuelled fear, the IHU strain has been met with a ‘shrug of the shoulders’
The World Health Organization has downplayed the threat of a new Covid variant with 46 mutations that was discovered in France.
Nicknamed IHU after it was reported by researchers at the IHU Mediterranee Infection institute in Marseille in October, the B.1.640.2 variant has been found in around 20 samples sequenced so far – and in only one since early December, reported The New York Times.
Dr Abdi Mahamud, a WHO incident manager on Covid, told a press briefing in Geneva this week that it “has been on our radar” but it is not currently a variant of concern.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
‘Shrug of the shoulders’
“Another day, another variant,” said Samuel Lovett, The Independent’s science correspondent. While the reaction to Omicron among many scientists was “laced with genuine fear and concern”, the new strain has been met with “a shrug of the shoulders”.
It was first detected in October and uploaded to the disease variant database Gisaid on 4 November. With its 46 mutations, many of which are on its spike protein, B.1.640.2 looks “problematic” on paper, said Lovett. “In reality, this is a variant that predates Omicron yet has failed to take off globally in the same way.”
The reason for this is unknown. Despite its mutations, “much depends on how they combine with one another to shape the characteristics of the virus”, explained Lovett. Only when scientists have more data will they be able to answer why it has not come to dominate like Omicron.
Origins
In a pre-print study uploaded to MedRxiv on 29 December, the IHU team said the first detected case was found in southeastern France in a vaccinated person who had recently travelled from Cameroon. The researchers’ report is yet to be peer reviewed.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tom Peacock, a virologist at Imperial College London, noted on Twitter this week that there had been “lots of chat about B.1.640.2 in the last few days”, but that it was not a variant “worth worrying about too much” at the moment. The virus has “had a decent chance to cause trouble” yet this “never really materialised”.
Making a similar point, the WHO’s Mahamud told reporters that the virus “has had a lot of chances to pick up”, but has not spread widely over the past two months.
‘Different not necessarily worse’
Does the discovery of B.1.640.2 mean the sky is falling and we should be panicking? “Umm, no,” said Bruce Y. Lee, a professor of health policy and writer for Forbes.
For a variant to become one of concern, there has to be evidence that it is more transmissible, more likely to cause severe Covid-19 or more likely to evade immunity than its predecessors. “Different doesn’t necessarily mean worse,” said Lee.
However, he thinks it does “merit some close watching”. For now, he concluded, “consider this to be a variant of we-don’t-know-what-this-means-because-there-haven’t-been-enough-data-and-studies-yet-to-tell-please-do-not-jump-to-conclusions”.
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published